Sale!

WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test

Original price was: $700.Current price is: $500.

-29%

The WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the WWOX gene associated with spinocerebellar ataxia type 12. This comprehensive genetic analysis utilizes next-generation sequencing technology to detect autosomal recessive inheritance patterns of this progressive neurological condition. The test provides crucial information for individuals experiencing coordination difficulties, balance problems, or those with family history of ataxia disorders. Early detection through this $500 USD test enables proactive management strategies and informed family planning decisions. Results are typically available within 3-4 weeks from sample collection.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing methodology provides crucial insights into one of the rarest forms of hereditary ataxia, offering patients and healthcare providers definitive answers about genetic predisposition to this progressive neurological condition.

What This Test Measures and Detects

Our specialized genetic test focuses on comprehensive analysis of the WWOX (WW Domain Containing Oxidoreductase) gene using next-generation sequencing technology. The test specifically identifies:

  • Pathogenic variants in the WWOX gene associated with spinocerebellar ataxia type 12
  • Autosomal recessive inheritance patterns of the condition
  • Specific mutations that disrupt normal cerebellar function
  • Genetic markers indicating increased risk for neurological degeneration
  • Carrier status for family planning purposes

Who Should Consider This Genetic Test

This comprehensive genetic analysis is recommended for individuals experiencing:

  • Progressive coordination difficulties and balance problems
  • Family history of spinocerebellar ataxia or similar neurological conditions
  • Unexplained gait abnormalities or difficulty with fine motor skills
  • Early-onset cerebellar symptoms without clear diagnosis
  • Planning pregnancy with known family history of neurological disorders
  • Suspected autosomal recessive inheritance patterns in family medical history

Clinical Benefits of Genetic Testing

Undergoing the WWOX Gene Spinocerebellar Ataxia Type 12 test provides numerous advantages:

  • Early Intervention Opportunities: Identify genetic predisposition before significant symptoms develop
  • Personalized Treatment Planning: Develop targeted management strategies based on genetic findings
  • Family Planning Guidance: Make informed reproductive decisions with complete genetic information
  • Reduced Diagnostic Uncertainty: Eliminate years of uncertainty and multiple specialist consultations
  • Proactive Health Management: Implement preventive measures and monitoring protocols
  • Psychological Relief: Gain clarity and reduce anxiety about unexplained neurological symptoms

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your results with clarity:

  • Positive Result: Indicates presence of WWOX gene mutations associated with spinocerebellar ataxia type 12. Our genetic counselors provide detailed guidance on management strategies and family implications.
  • Negative Result: Suggests absence of the specific genetic variants tested. However, continued monitoring may be recommended based on clinical presentation.
  • Variant of Uncertain Significance: Some genetic changes require additional research. We provide ongoing support and updates as scientific understanding evolves.
  • Carrier Status: Identifies individuals who carry one copy of the mutated gene but typically don’t show symptoms, important for family planning decisions.

Test Details and Pricing

Test Component Details
Test Name WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure accurate results and comprehensive care, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create detailed family pedigree chart
  • Documentation of affected family members with similar neurological symptoms
  • Neurological evaluation when clinically indicated

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures you receive comprehensive care regardless of your location.

Take Control of Your Neurological Health

Don’t let uncertainty about genetic predisposition to neurological conditions affect your quality of life. Our WWOX Gene Spinocerebellar Ataxia Type 12 test provides the clarity you need to make informed healthcare decisions and plan for your future with confidence.

Ready to take the next step? Book your genetic test today by calling our dedicated genetic counseling team at +1(267) 388-9828 or schedule your appointment online. Early detection leads to better outcomes – invest in your neurological health now.